Each uncoated tablet contains :
Metformin Hydrochloride BP 500 mg
Gliclazide BP 80 mg
Non-insulin dependent diabetes mellitus, diabetes with or without obesity in adults.
Dibchek-GL is a combination of Gliclazide and Metformin hydrochloride. Gliclazide is a sulphonylurea which reduces blood glucose level by stimulating the release of insulin from pancreatic cells. Metformin is a biguanide which improves hepatic and peripheral tissue sensitivity to insulin hence improves glucose tolerance in patients with Type II diabetes. It reduces the amount of glucose produced by liver and absorbed by small intestine.
Dibchek-GL is contraindicated in patients with known hypersensitivity to any of the ingredients of the product and in conditions such as insulin-dependent diabetes mellitus, renal or hepatic failure, alcoholism, cardiac failure, pregnancy, lactation and patients undergoing surgery.
Hypoglycaemia, skin eruption, nausea, vomiting, diarrhoea, metallic taste in mouth may occur occasionally. Symptoms of side effects (if any) should subside after discontinuing medicine. If symptoms persist, please consult physician.
As directed by the physician.
Store in a cool, dark & dry place. Keep out of reach of children.
Dibchek-GL tablets are available in the pack of 10×10 tablets.